LKB1 Deletion Causes Early Changes in Atrial Channel Expression and Electrophysiology Prior to Atrial Fibrillation
Overview
Authors
Affiliations
Aims: Liver kinase B1 (LKB1) is a protein kinase that activates the metabolic regulator AMP-activated protein kinase (AMPK) and other related kinases. Deletion of LKB1 in mice leads to cardiomyopathy and atrial fibrillation (AF). However, the specific role of the LKB1 pathway in early atrial biology remains unknown. Thus, we investigated whether LKB1 deletion altered atrial channel expression and electrophysiological function in a cardiomyocyte-specific knockout mouse model.
Methods And Results: We performed a systematic comparison of αMHC-Cre LKB1(fl/fl) and littermate LKB1(fl/fl) male mice. This included analysis of gene expression, histology, and echocardiography, as well as cellular and tissue-level electrophysiology using patch-clamp recordings in vitro, optical mapping ex vivo, and ECG recordings in vivo. At postnatal day 1, atrial depolarization was prolonged, and Nav1.5 and Cx40 expression were markedly down-regulated in MHC-Cre LKB1(fl/fl) mice. Inward sodium current density was significantly decreased in MHC-Cre LKB1(fl/fl) neonatal atrial myocytes. Subsequently, additional alterations in atrial channel expression, atrial fibrosis, and spontaneous onset of AF developed by 2 weeks of age. In adult mice, abnormalities of interatrial conduction and bi-atrial electrical coupling were observed, likely promoting the perpetuation of AF. Mice with AMPK-inactivated hearts demonstrated modest overlap in channel expression with MHC-Cre LKB1(fl/fl) hearts, but retained normal structure, electrophysiological function and contractility.
Conclusions: Deletion of LKB1 causes early defects in atrial channel expression, action potential generation and conduction, which precede widespread atrial remodelling, fibrosis and AF. LKB1 is critical for normal atrial growth and electrophysiological function.
Wang A, Hu H, Zhang D, Qian G, Pan H, Zhai C Clin Cardiol. 2025; 48(3):e70085.
PMID: 40051296 PMC: 11885888. DOI: 10.1002/clc.70085.
Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera J, Chugh S Europace. 2024; 26(9).
PMID: 39077825 PMC: 11431804. DOI: 10.1093/europace/euae204.
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights.
Sarkar A, Fanous K, Marei I, Ding H, Ladjimi M, MacDonald R Vasc Health Risk Manag. 2024; 20:255-288.
PMID: 38919471 PMC: 11198029. DOI: 10.2147/VHRM.S391808.
Altieri D, Etzion Y, Anderson H Front Pharmacol. 2023; 14:1142583.
PMID: 37113758 PMC: 10126395. DOI: 10.3389/fphar.2023.1142583.
Mouse models of spontaneous atrial fibrillation.
Keefe J, Hulsurkar M, Reilly S, Wehrens X Mamm Genome. 2022; 34(2):298-311.
PMID: 36173465 PMC: 10898345. DOI: 10.1007/s00335-022-09964-x.